Infectious Disease Rapid Diagnostic Testing Market
Infectious Disease Rapid Diagnostic Testing Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Infectious Disease Rapid Diagnostic Testing Market
Size and Growth
The Infectious Disease Rapid Diagnostic Testing market is experiencing significant growth, driven by increasing demand for quick and accurate diagnostic solutions. The market size is projected to reach approximately $5.1 billion by 2026, fueled by technological advancements and rising incidences of infectious diseases globally, emphasizing the need for efficient diagnostic methods. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Roche Ltd
◍ Danaher Corporation
◍ Luminex Corporation
◍ BGI Group
◍ bioMerieux S.A.
◍ DiaSorin S.p.A
◍ Hologic, Inc.
◍ Mesa Biotech
◍ Quidel Corporation
◍ Thermo Fisher Scientific Inc.
◍ GenMark Diagnostics
◍ CTK Biotech
◍ Becton Dickinson
◍ Cellex Inc.
The Infectious Disease Rapid Diagnostic Testing Market features major players like Abbott Laboratories, Roche Ltd, and Danaher Corporation. These companies innovate testing solutions, enhance accessibility and efficiency, and leverage advanced technologies to grow the market. Sales figures include: Abbott: $43B, Roche: $63B, Thermo Fisher: $30B.
Request Sample Report
Market Segmentation
By Application
◍ Respiratory Infection
◍ Gastro-Intestinal Infection
◍ Center Nervous System Infection
◍ Hospital Acquired Infection
◍ Sexually Transmitted Infections
◍ Others
By Product
◍ Assays
◍ Platforms
Request Sample Report
Market Growth
Request Sample Report
$ 79.69 Billion
